Company Accounts and Tax Online 11250014 Board of Directors 1.4.24 31.3.25 31.3.25 No description of principal activity true 11250014 uk-bus:EntityHasNeverTraded 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure 11250014 2023-04-01 2024-03-31 11250014 2025-03-31 11250014 2024-04-01 2025-03-31 11250014 2024-03-31 11250014 countries:EnglandWales 2024-04-01 2025-03-31 11250014 curr:PoundSterling 2024-04-01 2025-03-31 11250014 uk-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 11250014 uk-bus:Micro-entities 2024-04-01 2025-03-31 11250014 uk-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 11250014 uk-bus:FullAccounts 2024-04-01 2025-03-31 11250014 uk-bus:RegisteredOffice 2024-04-01 2025-03-31 11250014 uk-bus:Director1 2024-04-01 2025-03-31 11250014 uk-bus:Director1 2024-04-01 11250014 uk-bus:Director1 2025-03-31 11250014 core:AfterOneYear 2025-03-31 11250014 core:AfterOneYear 2024-03-31 11250014 core:WithinOneYear 2025-03-31 11250014 core:WithinOneYear 2024-03-31 11250014 core:WithinOneYear 2024-04-01 2025-03-31 11250014 core:AfterOneYear 2025-03-31 11250014 core:AfterOneYear 2024-03-31 11250014 core:AfterOneYear 2024-04-01 2025-03-31 11250014 core:ShareCapital 2025-03-31 11250014 core:ShareCapital 2024-03-31 11250014 core:RevaluationReserve 2025-03-31 11250014 core:RevaluationReserve 2024-03-31 11250014 core:RetainedEarningsAccumulatedLosses 2025-03-31 11250014 core:RetainedEarningsAccumulatedLosses 2024-03-31 11250014 1 2024-04-01 2025-03-31

# DOWRGONNA (PHARMA) CONSULTING LIMITED

## Company Registration Number:
11250014 (England and Wales)

## Unaudited micro entity accounts for the year ended 31 March 2025

## (Dormant)

## Period of accounts

## Start date: 01 April 2024

## End date: 31 March 2025

# DOWRGONNA (PHARMA) CONSULTING LIMITED

## Contents of the Financial Statements

for the Period Ended 31 March 2025

Company Information - 3 |
Report of the Directors - 4 |
Profit and Loss Account - 5 |
Balance sheet - 6 |
Footnotes to the Balance Sheet - 8 |

# DOWRGONNA (PHARMA) CONSULTING LIMITED

## Company Information

for the Period Ended 31 March 2025

Director: |  | Andrew James
Registered office: |  | 3 Higher Tamar Terrace Gunnislake GBR PL18 9LP
Company Registration Number: |  | 11250014 (England and Wales)

# DOWRGONNA (PHARMA) CONSULTING LIMITED

## Directors' Report Period Ended 31 March 2025

The directors present their report with the financial statements of the company for the period ended 31 March 2025

Directors

The directors shown below have held office during the whole of the period from 01 April 2024 to 31 March 2025
Andrew James

The company was dormant and did not trade in the period.

This report was approved by the board of directors on 20 June 2025
And Signed On Behalf Of The Board By:

Name: Andrew James
Status: Director

# DOWRGONNA (PHARMA) CONSULTING LIMITED

## Profit and Loss Account

for the Period Ended 31 March 2025

The company was dormant and did not trade in the period. The company received no income and incurred no expenditure in the period and therefore did not make either a profit or loss.

# DOWRGONNA (PHARMA) CONSULTING LIMITED

## Balance sheet

As at 31 March 2025

| 2025 £ | 2024 £
--- | --- | ---
Called up share capital not paid: | 0 | 0
Fixed Assets: | 0 | 0
Current assets: | 0 | 0
Prepayments and accrued income: | 0 | 0
Creditors: amounts falling due within one year: | ( 0 ) | ( 0 )
Net current assets (liabilities): | 0 | 0
Total assets less current liabilities: | 0 | 0
Creditors: amounts falling due after more than one year: | ( 0 ) | ( 0 )
Provision for liabilities: | ( 0 ) | ( 0 )
Accruals and deferred income: | ( 0 ) | ( 0 )
Total net assets (liabilities): | 0 | 0
Capital and reserves: | 0 | 0

# DOWRGONNA (PHARMA) CONSULTING LIMITED

## Balance sheet continued

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

For the year ending 31 March 2025 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.

This report was approved by the board of directors on 20 June 2025
And Signed On Behalf Of The Board By:

Name: Andrew James
Status: Director

The notes form part of these financial statements

# DOWRGONNA (PHARMA) CONSULTING LIMITED

## Footnotes to the Financial Statements

for the Period Ended 31 March 2025

- ## 1. Employee Information

  Average number of employees: 0

# DOWRGONNA (PHARMA) CONSULTING LIMITED

## Footnotes to the Financial Statements

for the Period Ended 31 March 2025

- ## 2. Off balance sheet disclosure

  No